PHARMACEUTICALS TREATMENT PREVENTION
| Brand | Owner (click to sort) | Address | Description |
|---|---|---|---|
| KUNECSA | VIVUS, INC. | 900 E. Hamilton Ave., Suite 550 Campbell CA 95008 | Pharmaceuticals for treatment and prevention of diseases and conditions in humans; pharmaceuticals for the treatment of erectile dysfunction and sexual dysfunctions and disorders in males and females, for the maintenance of sexual health, for treatment of menopause and post-menopause symptoms and conditions, for treatment of hormonal disorders, for use in the treatment and prevention of endometriosis, osteoporosis, urinary incontinence and infertility, for the treatment of obesity, to facilitate weight loss and weight control, to suppress appetite and lower the threshold for satiety, for treatment of metabolic disorders, for treatment of diabetes, cardiovascular disorders and cardiovascular diseases in humans, and for treatment of sleep disorders and neurodegenerative diseases; contraceptive preparations for use in humans; |
| QNECSA | VIVUS, INC. | 900 E. Hamilton Ave., Suite 550 Campbell CA 95008 | Pharmaceuticals for treatment and prevention of diseases and conditions in humans; pharmaceuticals for the treatment of erectile dysfunction and sexual dysfunctions and disorders in males and females, for the maintenance of sexual health, for treatment of menopause and post-menopause symptoms and conditions, for treatment of hormonal disorders, for use in the treatment and prevention of endometriosis, osteoporosis, urinary incontinence and infertility, for the treatment of obesity, to facilitate weight loss and weight control, to suppress appetite and lower the threshold for satiety, for treatment of metabolic disorders, for treatment of diabetes, cardiovascular disorders and cardiovascular diseases in humans, and for treatment of sleep disorders and neurodegenerative diseases; contraceptive preparations for use in humans; |
| QNISA | VIVUS, INC. | 900 E. Hamilton Ave., Suite 550 Campbell CA 95008 | Pharmaceuticals for treatment and prevention of diseases and conditions in humans; pharmaceuticals for the treatment of erectile dysfunction and sexual dysfunctions and disorders in males and females, for the maintenance of sexual health, for treatment of menopause and post-menopause symptoms and conditions, for treatment of hormonal disorders, for use in the treatment and prevention of endometriosis, osteoporosis, urinary incontinence and infertility, for the treatment of obesity, to facilitate weight loss and weight control, to suppress appetite and lower the threshold for satiety, for treatment of metabolic disorders, for treatment of diabetes, cardiovascular disorders and cardiovascular diseases in humans, and for treatment of sleep disorders and neurodegenerative diseases; contraceptive preparations for use in humans; |
| QSIVA | VIVUS, INC. | 900 E. Hamilton Ave., Suite 550 Campbell CA 95008 | Pharmaceuticals for treatment and prevention of diseases and conditions in humans; pharmaceuticals for the treatment of erectile dysfunction and sexual dysfunctions and disorders in males and females, for the maintenance of sexual health, for treatment of menopause and post-menopause symptoms and conditions, for treatment of hormonal disorders, for use in the treatment and prevention of endometriosis, osteoporosis, urinary incontinence and infertility, for the treatment of obesity, to facilitate weight loss and weight control, to suppress appetite and lower the threshold for satiety, for treatment of metabolic disorders, for treatment of diabetes, cardiovascular disorders and cardiovascular diseases in humans, and for treatment of sleep disorders and neurodegenerative diseases; contraceptive preparations for use in humans; |
| QVESA | VIVUS, INC. | 900 E. Hamilton Ave., Suite 550 Campbell CA 95008 | Pharmaceuticals for treatment and prevention of diseases and conditions in humans; pharmaceuticals for the treatment of erectile dysfunction and sexual dysfunctions and disorders in males and females, for the maintenance of sexual health, for treatment of menopause and post-menopause symptoms and conditions, for treatment of hormonal disorders, for use in the treatment and prevention of endometriosis, osteoporosis, urinary incontinence and infertility, for the treatment of obesity, to facilitate weight loss and weight control, to suppress appetite and lower the threshold for satiety, for treatment of metabolic disorders, for treatment of diabetes, cardiovascular disorders and cardiovascular diseases in humans, and for treatment of sleep disorders and neurodegenerative diseases; contraceptive preparations for use in humans; |
Where the owner name is not linked, that owner no longer owns the brand |
Technical Examples
- The present invention is a method for the treatment or prevention of preferably non-insulin dependent (NIDDM or so-called Type II) diabetes mellitus, or other conditions associated with impaired glucose tolerance such as obesity, and in particular to the use of phytanic acid derivatives for the said treatment and/or prevention. A method of making a composition for the treatment or prevention of non-insulin dependent diabetes mellitus and related diseases comprising combining phytanic acid or derivatives thereof with a pharmaceutically acceptable additive or adjuvant, and a composition for the treatment or prevention of non-insulin dependent diabetes mellitus comprising phytanic acid or derivatives thereof are also provided.